Bayer/BAYN

€28.61

-1.99%
-
1D1W1MYTD1YMAX

About Bayer

Bayer AG is a German-based life science company. The Company's segments are Pharmaceuticala and Consumer Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The Company is focusing on their oncology platform for Targeted Alpha Therapies for treating prostate cancer. The Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment has been moved to Cinven which operates as an independent company called Envu.

Ticker

BAYN

Sector

Healthcare

Trading on

XETRA

Industry

Biotechnology & Drugs

CEO

Employees

100,873

Headquarters

Leverkusen, Germany

Bayer Metrics

BasicAdvanced
€28.62B
Market cap
-
P/E ratio
-€3.73
EPS
1.06
Beta
€2.40
Dividend rate
0.38%
Dividend yield

Bayer Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-44.17% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
€10.34B
-6.36%
Net income
€-4.57B
142.13%
Profit margin
-44.17%
158.61%

Bayer Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 45.3%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
€1.35
€2.95
€1.22
€0.38
-
Expected
€1.32
€2.88
€1.26
€0.69
€1.29
Surprise
2.56%
2.61%
-3.27%
-45.3%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by ICE Data Services and Deutsche Börse. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Bayer stock

Buy or sell Bayer stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing